Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions

Published on Nov 5, 2020in Nanoscale7.79
路 DOI :10.1039/D0NR06271E
Bin Zhang21
Estimated H-index: 21
(SZU: Shenzhen University)
In recent years, nanomaterials and nanotechnology have emerged as vital factors in the medical field with a unique contribution to cancer medicine. Given the increasing number of cancer patients, it is necessarily required to develop innovative strategies and therapeutic modalities to tackle hypoxia, which forms a hallmark and great barrier in treating solid tumors. The present review details the challenges in nanotechnology-based hypoxia, targeting the strategies and solutions for better therapeutic performances. The interaction between hypoxia and tumor is firstly introduced. Then, we review the recently developed engineered nanomaterials towards multimodal hypoxia tumor therapies, including chemotherapy, radiotherapy, and sonodynamic treatment. In the next part, we summarize the nanotechnology-based strategies for overcoming hypoxia problems. Finally, current challenges and future directions are proposed for successfully overcoming the hypoxia tumor problems.
馃摉 Papers frequently viewed together
#1Xu Zhangting (Tongji University)H-Index: 1
#2Chang Pan (Tongji University)H-Index: 1
Last. Weizhong Yuan (Tongji University)H-Index: 1
view all 3 authors...
Hypoxia is an important pathological phenomenon due to the uncontrolled cancer cell proliferation and insufficient blood flow, which could be used to design hypoxia-responsive nanocarriers for the intelligent treatment of tumor. However, it is difficult for the degree of hypoxia in tumor site to lead to the corresponding response of hypoxia-responsive polymers. Therefore, hypoxia-responsive azobenzene-centered copolymers poly oligo (ethylene glycol) methacrylate-block-poly(e-caprolactone)-azoben...
#1Chao Zhang (NU: Nanjing University)H-Index: 139
#2Weizhi Chen (NU: Nanjing University)H-Index: 1
Last. Yong Hu (NU: Nanjing University)H-Index: 24
view all 5 authors...
Photodynamic therapy (PDT), as a robust strategy, has long been applied to cancer treatment owing to the meaningful breakthroughs and unique advantages, including ignorable invasiveness and spatio-temporal selectivity. Numerous PDT agents, especially hybrid nanoparticle composite (hybrid)-based sensitizers consisting of an organic polymer and inorganic nanoparticles (NPs), feature the synergetic pros of the components, which have unlocked the additional potentials of PDT. Although reviews relati...
#1Xinqiang WuH-Index: 2
#2Xiaofeng JiangH-Index: 10
Last. Han Zhang (SZU: Shenzhen University)H-Index: 136
view all 15 authors...
Photodynamic therapy (PDT) is a promising non-invasive therapy approach for various diseases including malignant tumor. The process of PDT involves three interrelated aspects, namely photosensitizer (PS), light source, and oxygen, among which PS is the decisive factor that determines its anticancer efficiency. There exist some defects in currently applied PDT, such as inadequate production of reactive oxygen species (ROS), poor penetration of exciting light, insufficient oxygen supply, and nonse...
#1Ping Yan (Southern Medical University)H-Index: 1
Due to its high tissue penetrative depth, high remote spatio-temporal selectivity and non-invasive therapeutic features, sonodynamic therapy (SDT) has received great attention in recent years. In t...
#1Hanjie Wang (TJU: Tianjin University)H-Index: 30
#2Chaonan Zhang (TJU: Tianjin University)H-Index: 5
Last. Jin Chang (TJU: Tianjin University)H-Index: 64
view all 8 authors...
Abstract: Photodynamic therapy (PDT) is an oxygen-dependent, non-invasive cancer treatment. The hypoxia in the tumor environment limited the therapeutic effects of PDT. Combined delivery of hypoxic prodrugs and photosensitizers is a promising approach to enhance the PDT efficiency. In this paper, an erythrocyte and tumor cell membrane camouflage nanocarrier co-loaded with photosensitizer (Indocyanine green) and hypoxic prodrug (Tirapazamine), which was used to combine PDT with chemotherapy. The ...
Remarkable progress has been made in the development of new therapies for cancer, dramatically changing the landscape of treatment approaches for several malignancies and continuing to increase patient survival. Accordingly, adverse effects of cancer therapies that interfere with the continuation of best-possible care, induce life-threatening risks or lead to long-term morbidity are gaining increasing importance. Cardiovascular toxic effects of cancer therapeutics and radiation therapy are the e...
#1Chuanhui Song (NU: Nanjing University)H-Index: 9
#2Wenguang Xu (NU: Nanjing University)H-Index: 9
Last. Wei Han (NU: Nanjing University)H-Index: 14
view all 9 authors...
Hypoxia, a state of low oxygen tension in solid tumors, is not only closely correlated with resistance to both radiotherapy and chemotherapy, but also associated with poor prognosis of tumors and regional lymph node status. Herein, based on the analysis of cell samples from tumor patients, low-density lipoprotein receptor (LDLR) was found overexpressed on the surface of hypoxic tumor cell membranes, and confirmed an effective hypoxia marker through specific binding with anti-LDLR antibody in sol...
#6Tingting Zheng (PKU: Peking University)H-Index: 3
#7Yun Chen (PKU: Peking University)H-Index: 3
Abstract Photodynamic therapy (PDT), as a non-invasive therapeutic modality that is alternative to radiotherapy and chemotherapy, is extensively investigated for cancer treatments. Although conventional organic photosensitizers (PSs) are still widely used and have achieved great progresses in PDT, the disadvantages such as hydrophobicity, poor stability within PDT environment and low cell/tissue specificity largely limit their clinical applications. Consequently, nano-agents with promising physi...
#1Dongbo Guo (SCUT: South China University of Technology)H-Index: 8
#2Shuting Xu (SJTU: Shanghai Jiao Tong University)H-Index: 8
Last. Xinyuan Zhu (SJTU: Shanghai Jiao Tong University)H-Index: 69
view all 8 authors...
Despite the great advances achieved in hypoxia-associated tumor therapy, the efficacy of hypoxia-activated prodrugs alone is usually limited owing to the moderate oxygen supply at the tumor area. Herein, we develop a polymerized platinum(IV) compound-based nanogel (polyprodrug) containing a bioreductive and hypoxia-activated prodrug (tirapazamine, TPZ) as a prodrug combo (polyprodrug@TPZ) for synergistic chemotherapy. Upon exposure to the tumor microenvironment, platinum(IV) moieties in the poly...
#1Sairan Eom (Ewha Womans University)H-Index: 3
#2Goeun Choi (DU: Dankook University)H-Index: 18
Last. Jin-Ho Choy (DU: Dankook University)H-Index: 76
view all 4 authors...
In the last several decades, 2-dimensional (2D) nanomaterials have been studied in various bio-fields such as drug delivery systems, diagnostic and imaging materials, etc. In particular, many inves...
Cited By2
#3Lei Wang (CAS: Chinese Academy of Sciences)H-Index: 69
Abstract null null Therapeutic resistance caused by hypoxia tumor microenvironment (TME) is one of the main challenges for the development of nanoscale delivery systems, particular for the photodynamic agents. In this work, porphyrin-based metal-organic frameworks composite ACF@PCN-222@MnO2-PEG (APM) with the mimetic sea cucumber morphology was post-synthesized for using in photodynamic therapy (PDT) against hypoxia. Besides the good colloidal stability, as-synthesized APM nanoparticles also exh...
#1Dong LiH-Index: 1
#2Jie PanH-Index: 1
Last. Gang Liu
view all 6 authors...
Recently, second near-infrared (NIR-II) fluorescent imaging has been widely applied in biomedical diagnosis, due to its high spatiotemporal resolution and deep tissue penetration. In contrast to the 鈥渁lways on鈥 NIR-II fluorescent probes, the activatable NIR-II fluorescent probes have specific targeting to biological tissues, showing a higher imaging signal-to-background ratio and a lower detection limit. Therefore, it is of great significance to utilize disease-associated endogenous stimuli (suc...
Due to their prominent physicochemical properties, 2D materials are broadly applied in biomedicine. Currently, 2D materials have achieved great success in treating many diseases such as cancer and tissue engineering as well as bone therapy. Based on their different characteristics, 2D materials could function in various ways in different bone diseases. Herein, the application of 2D materials in bone tissue engineering, joint lubrication, infection of orthopedic implants, bone tumors, and osteoar...
#1Saurabh Satija (LPU: Lovely Professional University)H-Index: 18
#2Prabal Sharma (LPU: Lovely Professional University)H-Index: 1
Last. Hamid A. Bakshi (Ulster University)H-Index: 11
view all 15 authors...
With an estimated failure rate of about 90%, immunotherapies that are intended for the treatment of solid tumors have caused an anomalous rise in the mortality rate over the past decades. It is apparent that resistance towards such therapies primarily occurs due to elevated levels of HIF-1 (Hypoxia-induced factor) in tumor cells, which are caused by disrupted microcirculation and diffusion mechanisms. With the advent of nanotechnology, several innovative advances were brought to the fore; and, o...
#1Weicong Liu (SYSU: Sun Yat-sen University)H-Index: 3
#2Qianwen YanH-Index: 1
Last. Ying PanH-Index: 11
view all 9 authors...
In improving the tumor-targeting ability of metal鈥搊rganic frameworks (MOFs) for tumor therapy and avoiding the clearance as well as capture by the immune system, there are still several challenges, which limit the development and bio-applications of MOFs. To overcome these challenges, various targeted modification strategies have been proposed. Amongst all the strategies, a promising cell membrane coating method has been explored and utilized for the syntheses of new cell membrane biomimetic MOF...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.